"The monitoring, compliance of companies raising capital overseas with respect to the Prevention of Money Laundering Act (PMLA) should be left to agencies that have such regulatory powers namely the enforcement directorate and financial intelligence unit," said a source on condition of anonymity.
| SAT OVERRULED SEBI |
|
The regulator is also said to have brought to the notice of the ministry that the Securities Act doesn't have specific provisions to track flows raised overseas and to enforce the requirement of filing of returns. Experts opine that Sebi has limited powers compared to the Enforcement Directorate to monitor funds.
The Supreme Court in a ruling on Monday stated the regulator has the power to probe GDRs sold by Indian companies, backed by local shares, to foreign investors and listed on overseas exchanges.
Sebi had moved the apex court after the Securities and Appellate Tribunal (SAT) in a ruling in 2013 had held that the regulations of GDR was outside the purview of Sebi. SAT had set aside a Sebi order barring Pan Asia Advisors and its promoter Arun Panchariya from capital markets for 10 years for alleged manipulation in global securities by six Indian firms.
The ruling came as a major setback to Sebi and put a question mark on the various investigations that were pending with regulator relating to the GDR issuances. A stay order obtained by Sebi from the Supreme Court in the matter enabled it to continue the on-going investigations.
The modus operandi in these cases, as observed by Sebi, involved the issuing companies having the same set of initial investors, with a major portion of the GDR issue brought by the same set of clients. The trading and offloading of the GDRs used to happen between the same set of clients. Commenting on SC’s ruling, Vaneesa Abhishek, a Bombay High Court lawyer, says it was natural for Sebi to get jurisdiction over the GDRs.
“The ruling is an important one starting new stream of legal jurisprudence. After this, Sebi can exercise jurisdiction over financial products even if those are not strictly in regulatory purview as long as manipulation in issuance and trading of that financial product leads to adverse impact on securities market,” she said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)